The 3rd Consortium Meeting of the OPTOMICS project was hosted by the Institute of Translational Genomics on the Helmholtz Munich campus on 6-7 February 2025. In-depth discussions about project progress, mitigation strategies for potential risks, and ethical considerations of project outcomes were discussed. Furthermore, important decisions were made by the MSC about next steps to ensure we reach our project goals of producing a Digital Twin for Type-2 Diabetes and improve personalized healthcare. 

It was great to see the OPTOMICS Consortium members in person again and looking forward to continuing to work together!